Ownership history in EntryPoint Capital, LLC · 4 quarters on record
This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in LARIMAR THERAPEUTICS INC (LRMR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 53,321 | -960 | -1.8% | 0.08% | $203K | $3.81 |
| 2024 Q4 | ADDED | 54,281 | +36,045 | +197.7% | 0.09% | $210K | $3.87 |
| 2024 Q3 | ADDED | 18,236 | +4,309 | +30.9% | 0.07% | $119K | $6.55 |
| 2024 Q1 | INITIATED | 13,927 | — | — | 0.09% | $106K | — |
As of 2025 Q4 — sorted by position size